Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01239056 · ClinicalTrials.gov registry record
Evaluation of Pancreatic Pseudocyst Drainage With a Metal Stent
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 22
- Enrollment target
NCT01239056: Completed study, sponsored by University of Florida.
NCT01239056 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01239056 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to study the evaluation of the effectiveness of endoscopic Pancreatic Pseudocyst drainage using a metal stent.
Primary Outcome
Technical success was evaluated by the ability to achieved pseudocyst drainage after endoscopically placing a Fully Covered Self-expanding Metal Stent in the pseudocyst . Technical failure was evaluated by the inability to fully drain the pancreas pseudocyst after endoscopically placing a Fully Covered Self-expanding Mental Stent in the pseudocyst.
Interventions
- PROCEDURE Endoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2009-08 |
| Est. Completion | 2015-05 |
What the finished NCT01239056 record still lists
NCT01239056 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Endoscopy is the first listed.
NCT01239056 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01239056 about?
NCT01239056 is a clinical study titled "Evaluation of Pancreatic Pseudocyst Drainage With a Metal Stent". The purpose of this study is to study the evaluation of the effectiveness of endoscopic Pancreatic Pseudocyst drainage using a metal stent.
What is the current status of trial NCT01239056?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2009-08. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01239056?
The interventions under investigation include: Endoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT01239056?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia